Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ironwood Pharmaceuti (NQ: IRWD ) 7.040 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Ironwood Pharmaceuti < Previous 1 2 3 Next > Why Shares of VectivBio Holding Are Up Today May 22, 2023 A buyout offer by Ironwood Pharmaceuticals lifted the clinical-stage biotech's stock. Via The Motley Fool Merger Monday May 22, 2023 This morning, Chevron announced a deal to acquire PDC Energy for $72 per share in stock. Via Talk Markets Why VectivBio Shares Are Surging Monday May 22, 2023 VectivBio Holding AG (NASDAQ: VECT) shares are trading higher Monday after GI-focused healthcare company Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) agreed to Via Benzinga VectivBio Stock Catapults 38% After Ironwood Agrees To Buy It For $1 Billion May 22, 2023 Both companies are working on treatments for gastrointestinal diseases. Via Investor's Business Daily Benzinga Pro's Top 5 Stocks To Watch For Monday, May 22, 2023: MU, RKT, DLTR, LDOS, IRWD May 22, 2023 Micron Technology (MU) - Shares were down about 4% Monday morning following a report the Chinese government found cybersecurity issues related to Micron's products. Chinese officials have asked Via Benzinga Recap: Ironwood Pharmaceuticals Q1 Earnings May 04, 2023 Via Benzinga Earnings Scheduled For February 16, 2023 February 16, 2023 Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... Via Benzinga Earnings Outlook For Ironwood Pharmaceuticals February 15, 2023 Via Benzinga Earnings Scheduled For February 17, 2022 February 17, 2022 Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. Via Benzinga 3 No-Brainer Stocks to Buy Right Now for Less Than $25 February 04, 2023 All three healthcare stocks are showing solid long-term potential. Via The Motley Fool Why Ironwood Pharmaceuticals Shares Are Falling During Monday's Session January 09, 2023 Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) shares are trading lower by 10.00% to $11.30 Monday afternoon after the company cut its FY22 sales guidance below analyst estimates and issued FY23 sales... Via Benzinga Ironwood Pharmaceuticals: Q3 Earnings Insights November 03, 2022 Ironwood Pharmaceuticals (NASDAQ:IRWD) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Ironwood Shares Positive Top-line Data From Late-Stage Functional Constipation Candidate Study In Patients Aged 6-17 Years September 06, 2022 Ironwood Pharmaceuticals (NASDAQ: IRWD) announced positive top-line data from its Phase 3 clinical trial evaluating LINZESS (linaclotide) 72 mcg in pediatric patients aged 6-17 with functional... Via Benzinga Ironwood's Constipation Drug Shows Efficacy In Pediatric Patients September 06, 2022 Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) announced topline data from a Phase 3 trial evaluating Linzess (linaclotide) 72 mcg in pediatric patients aged 6-17 with functional constipation. Via Benzinga Wells Fargo Maintains Equal-Weight Rating for Ironwood Pharmaceuticals: Here's What You Need To Know August 16, 2022 Wells Fargo has decided to maintain its Equal-Weight rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) and raise its price target from $12.00 to $13.00. Shares of Ironwood Pharmaceuticals are trading... Via Benzinga 5 Value Stocks In The Healthcare Sector July 18, 2022 What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... Via Benzinga The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine May 25, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Via Benzinga Ironwood Pharmaceuticals: Q1 Earnings Insights May 05, 2022 Ironwood Pharmaceuticals (NASDAQ:IRWD) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Via Benzinga Ironwood Pharmaceuticals Q1 2022 Earnings Conference Call On May 5, 2022 At 08:30 AM ET April 29, 2022 Ironwood Pharmaceuticals (NASDAQ:IRWD) will host a conference call at 08:30 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. Via Benzinga 5 Value Stocks To Watch In The Healthcare Sector April 18, 2022 What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For April 22, 2022 April 22, 2022 Upgrades Via Benzinga Jefferies Raises Price Target On This Small-Cap 'Stand Out' Biotech Stock March 02, 2022 Ardelyx Inc (NASDAQ: ARDX) shares are trading higher after Jefferies upgraded shares to Buy from Hold and raised the price target on the stock to $5 from $1. Analyst... Via Benzinga A Look Into Healthcare Sector Value Stocks February 28, 2022 What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples... Via Benzinga Ironwood Pharmaceuticals Earnings Perspective: Return On Capital Employed February 18, 2022 According to Benzinga Pro data Ironwood Pharmaceuticals (NASDAQ:IRWD) posted a 25.91% decrease in earnings from Q3. Sales, however, increased by 12.9% over the previous quarter to $117.13 million. Via Benzinga Ironwood Reports Mixed Q4 Results; Linzess Joins Blockbuster Club As US Sales Exceed $1B February 17, 2022 Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) reported Q4 FY21 sales of $117.1 million, compared to $116.7 million in Q4 FY20, beating the consensus of $109.87 million.... Via Benzinga The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios February 17, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel... Via Benzinga Recap: Ironwood Pharmaceuticals Q4 Earnings February 17, 2022 Ironwood Pharmaceuticals (NASDAQ:IRWD) reported its Q4 earnings results on Thursday, February 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Earnings Outlook For Ironwood Pharmaceuticals February 16, 2022 Ironwood Pharmaceuticals (NASDAQ:IRWD) is set to give its latest quarterly earnings report on Thursday, 2022-02-17. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More February 13, 2022 Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... Via Benzinga Overview Of Value Stocks In The Healthcare Sector November 29, 2021 What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.